Browsing: Weight Loss

GLP-1 medications commonly used to manage type 2 diabetes and obesity may be associated with a modest increase in hair loss, according to a study published by The BMJ on July 22, 2026

Professor Sir Collin Tukuitonga, Co-Director of Te Poutoko Ora a Kiwa, Centre for Pacific and Global Health at Waipapa Taumata Rau, University of Auckland, has been appointed President-Elect of the World Obesity Federation, one of the world’s leading organisations addressing obesity prevention, treatment, advocacy, research and education

Rosie O’Donnell is opening up about her health journey and speaking out about going on Mounjaro for weight-loss

The U.S. healthcare system is at a critical juncture with rising obesity and chronic disease coupled with skyrocketing GLP-1 costs. Three in four (76.4%) U.S. adults have at least one chronic condition, and over half (51.4%) have two or more

For more than a decade, GLP-1 treatment for weight loss has required a weekly injection with a pre-filled pen that needed to be stored in the fridge. This acted as a barrier to entry for many potential patients who may be needle-averse or would struggle to stick to the strict storage and administration routine

Designed to balance blood sugar levels in patients with type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists gained fame through a distinct and significant side effect: weight loss. This sparked their approval as prescription drugs for weight management in obesity, making GLP-1 drugs one of the biggest pharmacological breakthroughs of the early 21st century

File photo of prison wire fencing. A Gobles man will spend nearly two years in federal prison for helping sell unapproved drugs imported from China, including some used for weight loss. (File/WWMT)

KALAMAZOO, Mich. —Weight loss drugs available to Kalamazoo County employees could be cut from coverage as leaders work to finalize the 2027 healthcare plan

Planning applications for hot food takeaways and fast-food outlets will be refused if they lie within 400m (1,300ft) of a school, a council has said

A new Ohio State University research study with the Ohio Restaurant and Hospitality Alliance shows the popularity of weight loss drugs like GLP-1 is changing the way people eat at restaurants. Nearly a quarter of American households report having at least one person using GLP-1